2014
DOI: 10.1007/s12024-014-9638-4
|View full text |Cite
|
Sign up to set email alerts
|

HbA1c method evaluation for postmortem samples

Abstract: Glycated hemoglobin (HbA1c) is used for diagnosis of diabetes and evaluation of the glycemic control of diabetics in clinical medicine. It is also a useful biomarker for analyzing postmortem samples, since it is relatively stable and correlates well with clinical samples. We wanted to evaluate the information provided by HbA1c analysis of postmortem blood samples using a HPLC based, fully automated analyzer. Autopsy data from 55 cases, in which glucose, lactate, ketone bodies, and HbA1c were analyzed as a part… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
3
0

Year Published

2016
2016
2021
2021

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 22 publications
0
3
0
Order By: Relevance
“…The amount of HbA1C is compared to total hemoglobin and gives an expression of the mean blood glucose level for the previous 2 months, which is the lifespan of the reds blood cells [7]. HbA1C has gained increased interest in postmortem diagnosis of diabetes because it is a stable and a useful marker of the ante-mortem blood glucose level within 2 month [7][8][9]. Due to a rapid decrease in blood glucose concentration after death, blood glucose cannot be used for reliable identification of diabetes in postmortem cases.…”
Section: Scandinavian Journal Of Nordisk Rettsmedisinmentioning
confidence: 99%
“…The amount of HbA1C is compared to total hemoglobin and gives an expression of the mean blood glucose level for the previous 2 months, which is the lifespan of the reds blood cells [7]. HbA1C has gained increased interest in postmortem diagnosis of diabetes because it is a stable and a useful marker of the ante-mortem blood glucose level within 2 month [7][8][9]. Due to a rapid decrease in blood glucose concentration after death, blood glucose cannot be used for reliable identification of diabetes in postmortem cases.…”
Section: Scandinavian Journal Of Nordisk Rettsmedisinmentioning
confidence: 99%
“…The amount of HbA 1c in the blood is dependent on mean glucose levels present during the 8–12 weeks preceding measurement, as HbA 1c accumulates in red blood cells during their 120-day lifespan, and therefore it is useful for long-term blood glucose control in diabetics [ 10–12 ]. For revealing undiagnosed or poorly managed diabetes in a post-mortem context, HbA 1c levels are useful for distinguishing diabetic ketoacidosis from starvation or alcoholic ketoacidosis, reveal death caused by hyperosmolar hyperglycaemic state [ 6 , 7 , 13–16 ] and diagnose fatal diabetic coma [ 17 ]. HbA 1c is relatively stable for analysing postmortem samples [ 18–20 ] and correlates well with clinical samples [ 19 ].…”
Section: Introductionmentioning
confidence: 99%
“…KEYWORDS: forensic science, glycated hemoglobin, HbA1c, diabetes mellitus, blood preservatives, ethylenediaminetetraacetic acid, sodium fluoride (NaF) Glycated hemoglobin (HbA1c) is used in postmortem investigations to detect undiagnosed or poorly managed diabetes mellitus (DM), in addition to differentiating between ketoacidosis and diabetic ketoacidosis (1)(2)(3)(4)(5)(6), making it an important biomarker in death investigation. HbA1c is formed from a nonenzymatic spontaneous reaction between glucose and the b-chain of hemoglobin (7)(8)(9). The fraction of hemoglobin that is glycated in the blood is determined by the amount of glucose present and the lifespan of erythrocytes, which is approximately 120 days (10,11).…”
mentioning
confidence: 99%